InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by DeVore Susan D., Director. Director active across 4 companies, notably Unum Group. Cumulatively, 17 filings have been recorded. Split: 1 buy · 1 sell. Total volume traded: €753k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 26 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to DeVore Susan D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
2,191 shares0Common StockSEC:0001587697-26-000011:0
563 shares0Common StockSEC:0001587697-26-000006:0
3,403 shares0Common StockSEC:0001587697-26-000004:0
1,980 shares0Common StockSEC:0001587697-26-000002:0
1,200 shares@ US$312.15100.0% of flowCommon StockSEC:0001587697-25-000007:0
Canonical exit: 17 Nov 2025 (T+90)
2,198 shares0Common StockSEC:0000005513-25-000094:0
601 shares0Common StockSEC:0001156039-25-000085:0
3,564 shares0Common StockSEC:0001628280-25-025961:0
5,577 shares@ US$80.6186100.0% of flowCommon StockSEC:0000005513-25-000035:0
3,342 shares0Common StockSEC:0000005513-24-000111:0
388 shares0Common StockSEC:0001156039-24-000081:0
3,839 shares0Common StockSEC:0000005513-23-000145:0
457 shares0Common StockSEC:0001156039-23-000068:0
4,448 shares0Common StockSEC:0000005513-22-000110:0
440 shares0Common StockSEC:0001156039-22-000068:0
416 shares0Common StockSEC:0001156039-21-000082:0
5,170 shares0Common StockSEC:0000005513-21-000112:0
17 of 17 declarations
About DeVore Susan D.
DeVore Susan D. is Administrateur. She has filed 17 filings in total, and, across the sampled recent filings, the reported amounts are EUR 321734 in purchases and EUR 431742 in sales, between 2021-06-01 and 2026-05-28. Her filings concern Unum Group, Elevance Health, Inc., Solventum Corp and Anthem, Inc.
